Your Search for adjuvant therapy matched 94 Documents (Page 1 of 4).
Results Indexed by relevance.
Abstract: Interleukin-2 may be a useful adjuvant therapy for patients with HIV infection, a report from the U.S. National Institutes of Health suggests. ...
http://www.aegis.org/pubs/aidswkly/2000/aw000308.html
File Name: aw000308.html, Size: 9KB, Last Modified: Monday, January 05, 2009 at 10:02:45 PM
Abstract: This prospective randomized trial was designed to evaluate the efficacy and safety of Intravenous Immune Globulin (IVIG) as adjuvant therapy to Ganciclovir for Cytomegalovirus ( CMV ) retinitis in patients with AIDS, given its efficacy in the treatment of CMV pneu ...
http://www.aegis.org/aidsline/1996/nov/m96b0651.html
File Name: m96b0651.html, Size: 10KB, Last Modified: Thursday, November 28, 1996 at 8:12:04 PM
Abstract: This report describes a computer program designed to assist health care professionals in making projections of the average benefit of systemic adjuvant therapy for individual breast cancer patients. It requires as input patient age (used to make projections of natural mortality), an estimate of breast cancer-related m ...
http://www.aegis.org/aidsline/1996/aug/m9681000.html
File Name: m9681000.html, Size: 9KB, Last Modified: Wednesday, August 28, 1996 at 8:12:04 PM
Abstract: Postulated mechanisms for lack of efficacy include underlying differences in the pathogenesis of CMV disease, the compounding effect of IVIG on graft versus host disease, inability to quantitate antibodies to gB and bH in a polyclonal preparation of IVIG and the poor penetration of IVIG across the blood retinal barrier ...
http://www.aegis.org/conferences/croi/1996/157.html
File Name: 157.html, Size: 8KB, Last Modified: Sunday, January 28, 1996 at 8:12:04 PM
Abstract: In advanced naïve patients, IL-2 adjuvant therapy is efficacious in inducing a rapid and significant CD4 reconstitution, in most cases sustained up to 18 months. The finding of a reduced prevalence of patients developing AIDS-defining conditions suggests a possible efficacy in functional immune enhancement which may tr ...
http://www.aegis.org/conferences/hiv-glasgow/2008/1758-2652-11-s1-p1.html
File Name: 1758-2652-11-s1-p1.html, Size: 7KB, Last Modified: Monday, November 10, 2008 at 7:00:00 AM
Abstract: <p><b>BACKGROUND:</b> Deficiency of the trace element selenium has been shown to dramatically increase the risk of HIV-1 related mortality. The present findings are based on recently completed studies to determine the impact of selenium chemoprevention on HIV disease progression. </p> <p><b>METHODS:</b> 259 HIV+ dru ...
http://www.aegis.org/conferences/iac/2002/wepeb5991.html
File Name: wepeb5991.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM
Abstract: Previous studies have suggested alterations in pulmonary surfactant lipid in the setting of Pneumocystis carinii pneumonia in HIV-infected patients. Because pulmonary surfactant lipid is composed of a variety of lipid products and because other phospholipids might be present in bronchoalveolar lavage (BAL) lipid deter ...
http://www.aegis.org/aidsline/1999/dec/a99c0690.html
File Name: a99c0690.html, Size: 10KB, Last Modified: Tuesday, December 28, 1999 at 8:12:04 PM
Abstract: Combination adjuvant therapy with intravenous dimethyl triazeno imidazole carboxamide (DTIC), 1-[4-amino-2-methyl-5-pyrimidinyl]-methyl-3-[2-chloroethyl]-3-nit- rosoure a hydrochloride (ACNU) and vincristine (VCR) and local injection of interferon-beta (IFN-beta) (DAV + IFN-beta therapy) has been widely applied to tre ...
http://www.aegis.org/aidsline/1999/jan/a9910589.html
File Name: a9910589.html, Size: 9KB, Last Modified: Thursday, January 28, 1999 at 8:12:04 PM
Abstract: OBJECTIVE: To evaluate the efficacy and safety of an intravenous human monoclonal antibody to cytomegalovirus ( CMV ), MSL-109, as adjuvant treatment for CMV retinitis. METHODS: Two hundred nine patients with acquired immunodef ...
http://www.aegis.org/aidsline/1998/feb/m9820012.html
File Name: m9820012.html, Size: 11KB, Last Modified: Sunday, March 01, 1998 at 6:29:23 AM
Abstract: In the December issue of the Archives of Opthamology, Dr. Douglas A. Jabs and colleagues from Johns Hopkins University report that MSL-109--the human monoclonal antibody of the IgG1 -kappa subclass that earlier demonstrated in vitro activity against cytomegalovirus--has now been found to be ineffective as an adjuvant ...
http://www.aegis.org/news/ads/1997/ad972329.html
File Name: ad972329.html, Size: 9KB, Last Modified: Monday, December 22, 1997 at 3:00:00 PM
Abstract: The aim of the work reported here was to evaluate the effects of an adjuvant treatment composed of an association of vitamins with an amino acid: beta-alanine, in cancer patients. This adjuvant therapy has been given to 17 subjects with a squamous cell carcinoma of upper aerodigestive tract treated by radiotherapy mos ...
http://www.aegis.org/aidsline/1993/aug/m9380497.html
File Name: m9380497.html, Size: 10KB, Last Modified: Saturday, August 28, 1993 at 8:12:04 PM
Abstract: STUDY OBJECTIVE: To determine the efficacy of dexamethasone as adjuvant therapy to improve pain relief in patients with severe, acute exudative pharyngitis. DESIGN: Prospective, randomized, double-blinded, placebo-controlled clinical trial. SETTING: Large, urban community hospital emergency department with an emergenc ...
http://www.aegis.org/aidsline/1993/may/m9350518.html
File Name: m9350518.html, Size: 10KB, Last Modified: Friday, May 28, 1993 at 8:12:04 PM
Abstract: The Scripps Memorial Hospitals Fourteenth Annual Cancer Symposium was held October 22-24, 1990, in La Jolla, CA. The five major sessions focused on hematology, evolution of multimodality therapy in gastrointestinal cancer, gynecological cancer, issues for the 1990s, breast cancer and AIDS. The following subjects were ...
http://www.aegis.org/aidsline/1992/aug/m9281114.html
File Name: m9281114.html, Size: 9KB, Last Modified: Friday, August 28, 1992 at 8:12:04 PM
Abstract: Earlier studies were have investigated the use of IL-7 to stimulate latently infected CD4 cells to express HIV and therefore render them susceptible to effect of antiretroviral treatment. If this response was sufficiently extensive and robust, this would re-open discussions on possibilities of HIV eradication. ...
http://www.aegis.org/pubs/i-base/2004/ib040506-08.html
File Name: ib040506-08.html, Size: 8KB, Last Modified: Thursday, May 21, 2009 at 9:28:34 PM
Abstract: ...
http://www.aegis.org/aidsline/1989/jul/m8970588.html
File Name: m8970588.html, Size: 7KB, Last Modified: Wednesday, January 07, 2009 at 5:26:07 AM
Abstract: Three types of human interferons (IFNs) are differentiated: alpha-interferon (with about 20 subtypes), beta-interferon, and gamma-interferon. In addition to their antiviral properties, these IFN types exert numerous other biological effects, which are increasingly exploited for therapeutic purposes. From 1982 to 1985 ...
http://www.aegis.org/aidsline/1988/jan/m8810336.html
File Name: m8810336.html, Size: 10KB, Last Modified: Wednesday, January 07, 2009 at 5:15:58 AM
Abstract: The purpose of this paper is to discuss a hypothesis corroborating the use of hydrolytic enzymes in AIDS/ARC/LAS patients, showing high levels of circulating immune complexes (CIC). Other diseases, revealing high CIC-levels as well, may be improved or even cured by eliminating CIC. The results obtained from experience ...
http://www.aegis.org/aidsline/1988/dec/m88c0599.html
File Name: m88c0599.html, Size: 9KB, Last Modified: Wednesday, January 07, 2009 at 5:14:53 AM
Abstract: Interferons (IFN) are potent antiviral, cytostatic-cytotoxic and immunomodulatory agents. Although gene technology has made available an unlimited supply of all different kinds and types of IFN, their basic modes of action have not been clarified up to now. The therapeutic effects proven differ gradually between the i ...
http://www.aegis.org/aidsline/1986/oct/m86a0038.html
File Name: m86a0038.html, Size: 10KB, Last Modified: Wednesday, January 07, 2009 at 5:01:02 AM
Abstract: Micronutrient supplementation can significantly improve CD4 cell count reconstitution in HIV-infected patients taking HAART. The micronutrient supplement tested was well-tolerated and may hold promise as an adjuvant therapy in the treatment of HIV. Further investigation is warranted. ...
http://www.aegis.org/conferences/iac/2006/moab0402.html
File Name: moab0402.html, Size: 9KB, Last Modified: Sunday, August 13, 2006 at 7:00:01 AM
Abstract: These results indicate that moderate exercise can decrease some components of mood disturbance among HIV+ individuals, leading to an improved quality of life, improved disease management, and slower progression of HIV disease. Exercise should continue to be explored as an adjuvant therapy for managing HIV symptoms and ...
http://www.aegis.org/conferences/iashivpt/2005/mope11-2c18.html
File Name: mope11-2c18.html, Size: 9KB, Last Modified: Monday, July 25, 2005 at 6:29:23 AM
Abstract: IL-2 during STI in patients treated during PHI is safe and is associated to HIV viremia control and CD4+ rise for 8 months after HAART discontinuation. Increase in HIV-specific responses suggests that IL-2 maintains CD4+ HIV-specific immunity, with no effect on CD8+ cytotoxicity. IL-2 leads to rises of naïve and centra ...
http://www.aegis.org/conferences/croi/2005/515.html
File Name: 515.html, Size: 8KB, Last Modified: Tuesday, February 22, 2005 at 8:12:04 PM
Abstract: Causes of TB treatment defaulting in poor resource settings are multi factorial, the most important of which being poor counseling on compliance, societal stigma discrimination and denial of TB patients, lower accessibility of heath facilities as well as poor service provider attitudes. These need to be addressed in cu ...
http://www.aegis.org/conferences/hiv-glasgow/2002/p310.html
File Name: p310.html, Size: 6KB, Last Modified: Sunday, November 17, 2002 at 8:12:04 PM
Abstract: Introduction Both HIV and testicular cancer commonly occur in young males. There have been conflicting reports as to the frequency and nature of HIV related testicular cancer (HT) and its treatment. We present a large series of HT addressing its presentation, therapy and prognosis. Patients and </p> <p><b>METHODS:</b> ...
http://www.aegis.org/conferences/iac/2002/thpeb7313.html
File Name: thpeb7313.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM
Abstract: The excess of seminoma supports the findings of large US cohort studies; other series from Europe have suggested an excess of mixed GCT and teratomas. The GCTs in this series present and should be treated as in the HIV-negative population. Chemotherapy and radiotherapy are well tolerated, but adversely affect the CD4 c ...
http://www.aegis.org/conferences/bhiva/2002/o25.html
File Name: o25.html, Size: 6KB, Last Modified: Friday, April 19, 2002 at 8:12:04 PM
Abstract: BACKGROUND: MHC class I restricted cytotoxic T cells (CTL) play an important in control of HIV infection. Augmentation of CTL responses is a desirable goal in the management of HIV disease. This study was aimed at evaluating HIV specific CD8 T-cell responses by ELISPOT assay and the effect of exogenous IL-15 on these r ...
http://www.aegis.org/conferences/croi/2002/230-t.html
File Name: 230-t.html, Size: 7KB, Last Modified: Sunday, February 24, 2002 at 8:12:04 PM
Abstract: BACKGROUND: Prostratin is a non-tumor promoting phorbol ester which inhibits de novo human immunodeficiency virus type-1 (HIV-1) infection yet up-regulates expression of latent pro-viral DNA. The lack of tumor promotion, block of viral spread, yet ability to induce latent proviral expression, suggests prostratin could ...
http://www.aegis.org/conferences/croi/2002/406-t.html
File Name: 406-t.html, Size: 7KB, Last Modified: Sunday, February 24, 2002 at 8:12:04 PM
Abstract: Our results indicate that progressive loss of nitric oxide production correlated with enhanced viral replication, increased lymphocyte depletion (apoptosis) and disease progression in HIV infection. Because NO has been described as an important microbicidal effector, impaired NO production could enhance the susceptibil ...
http://www.aegis.org/conferences/iashivpt/2001/280.html
File Name: 280.html, Size: 7KB, Last Modified: Monday, July 09, 2001 at 6:29:23 AM
Abstract: <p><b>BACKGROUND:</b> Our objective was to investigate whether the restoration of the CD4+ T-cell compartment following interleukin-2 ( IL-2 ) adjuvant therapy correlates with an increase both in phenotypically naïve T cells and in recent thymic emigrants. </p> <p><b>METHODS:</b> We evaluated ten HIV+ patients in trea ...
http://www.aegis.org/conferences/croi/2001/375.html
File Name: 375.html, Size: 5KB, Last Modified: Sunday, February 04, 2001 at 8:12:04 PM
Abstract: Thalidomide is increasingly being used as adjuvant therapy for patients with mycobacterial and human immunodeficiency virus (HIV) infections. The T-helper (Th)1 cytokine-Th2 cytokine balance critically determines the outcomes of these diseases. To obtain insight into the effect of thalidomide on the capacity of lympho ...
http://www.aegis.org/aidsline/2000/dec/a00c0693.html
File Name: a00c0693.html, Size: 10KB, Last Modified: Thursday, December 28, 2000 at 8:12:04 PM
Abstract: This study, using the MBT-2 murine bladder tumor model, mainly investigated the role of interleukin-12 (IL-12) in the specific antitumor immune response of a tumor-bearing host when systemically administrated after surgery. Day 17 tumor-bearing mice (D17TBM) along with non-tumor bearing naive mice were treated with da ...
http://www.aegis.org/aidsline/2000/oct/a00a0908.html
File Name: a00a0908.html, Size: 10KB, Last Modified: Saturday, October 28, 2000 at 8:12:04 PM